Dhingra Kapil 4
4 · Black Diamond Therapeutics, Inc. · Filed Jun 6, 2024
Insider Transaction Report
Form 4
Dhingra Kapil
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-06+30,550→ 30,550 totalExercise: $4.65Exp: 2034-06-05→ Common Stock (30,550 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 6, 2025 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service on such vesting date.